Abstract
Background:
The relationship between oxidative stress and osteoarthritis (OA) has been widely investigated. Serum malondialdehyde (MDA), nitric oxide (NO), and Cu/Zn superoxide dismutase (SOD) levels are useful markers of oxidative stress. Because of the importance of oxidative stress markers in the pathogenesis of OA, treatment might involve modification of these markers to control oxidative stress.
Objective:
The aim of this study was to compare the effects of 2 conventionalNSAIDs on markers of oxidative stress in patients with OA of the knee.
Methods:
This 3-week, prospective, randomized, open-label, active- and placebo-controlled study was conducted at the Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey. Adult patients with clinically and radiographically diagnosed moderate OA of the knee who were previously untreated were enrolled. Patients were randomly assigned to 1 of 3 treatment groups: flurbiprofen 100 mg PO (tablets) BID, tiaprofenic acid 300 mg PO (tablets) BID, or placebo tablets BID. Patients were evaluated using clinical assessment and laboratory testing before treatment (week 0; baseline) and at the end of week 3. The primary end points were the differences in serum MDA, NO, and SOD levels versus placebo. Clinical parameters-pain at rest and on motion-were evaluated using a 10-cm visual analog scale (0 = no pain to 10 = worst pain imaginable). The duration (in minutes) of morning stiffness was recorded by patients, using patient diaries. The differences between treatment groups were assessed using multivariate analysis.
Results:
Thirty-nine patients (20 women, 19 men; mean [SD] age, 59.0 [11.3]years) were included in the study. Mean serum MDA and NO levels were significantly decreased at 3 weeks compared with baseline in the 2 active-treatment groups (all, P < 0.001); these values remained statistically similar to baseline in the placebo group. Serum SOD levels were increased significantly from baseline in the 2 active-treatment groups (both, P < 0.001), but not in the placebo group. No significant differences in serum MDA and NO levels were found between the group receiving flurbiprofen and that receiving tiaprofenic acid. Serum SOD levels were significantly higher in the flurbiprofen group compared with the tiaprofenic acid and placebo groups (both, P < 0.01). The mean (SD) score for pain at rest was significantly lower at 3 weeks compared with baseline with flurbiprofen and tiaprofenic acid (both, P < 0.001), but not with placebo. The mean score for pain on motion was significantly reduced from baseline values only with tiaprofenic acid (P < 0.001). The duration of morning stiffness was significantly shorter at 3 weeks compared with baseline in all 3 study groups (all, P < 0.001). The mean scores for pain on motion and duration of morning stiffness were significantly reduced with tiaprofenic acid compared with placebo (both, P < 0.05). The study had some limitations (ie, small sample size, no blinding, the short duration of the study, and the weak correlation between serum and synovial fluid levels of NO).
Conclusions:
In this comparison of the effects of 3 weeks of treatment withflurbiprofen 100 mg BID and tiaprofenic acid 300 mg BID in patients with knee OA, both treatments effectively reduced serum MDA and NO levels compared with placebo. Only tiaprofenic acid significantly improved pain at rest and on motion and duration of morning stiffness compared with placebo.
Key words: osteoarthritis, malondialdehyde, nitric oxide, superoxide dismutase, NSAIDs
Full Text
The Full Text of this article is available as a PDF (580.9 KB).
References
- 1.Henrotin Y., Deby-Dupont G., Deby C. Active oxygen species, articular inflammation and cartilage damage. EXS. 1992;62:308–322. doi: 10.1007/978-3-0348-7460-1_31. [DOI] [PubMed] [Google Scholar]
- 2.Chen B.X., Francis M.J., Duthie R.B. Oxygen free radical in human osteoarthritis. Chin Med J (Engl). 1989;102:931–933. [PubMed] [Google Scholar]
- 3.Yudoh K., Nguyen T., Nakamura H. Potential involvement of oxidative stress in cartilage senescence and development of osteoarthritis: Oxidative stress induces chondrocyte telomere instability and downregulation of chondrocyte function. Arthritis Res Ther. 2005;7:R380–R391. doi: 10.1186/ar1499. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Tiku M.L., Shah R., Allison G.T. Evidence linking chondrocyte lipid peroxidation to cartilage matrix protein degradation. Possible role in cartilage aging and the pathogenesis ofosteoarthritis. J Biol Chem. 2000;275:20069–20076. doi: 10.1074/jbc.M907604199. [DOI] [PubMed] [Google Scholar]
- 5.Henrotin Y.E., Bruckner P., Pujol J.P. The role of reactive oxygen species in homeostasis and degradation of cartilage. Osteoarthritis Cartilage. 2003;11:747–755. doi: 10.1016/s1063-4584(03)00150-x. [DOI] [PubMed] [Google Scholar]
- 6.Mazzetti I., Grigolo B., Pulsatelli L. Differential roles of nitric oxide and oxygen radicals in chondrocytes affected by osteoarthritis and rheumatoid arthritis. Clin Sci (Lond). 2001;101:593–599. [PubMed] [Google Scholar]
- 7.Yang P., He X., Yang Z. Effects of bushen huoxue decoction on nitric oxide (NO) in serum, articular cartilage and synovium in rabbits of knee osteoarthritis. J Tradit Chin Med. 2004;24:149–152. [PubMed] [Google Scholar]
- 8.Pham T.N., Rahman P., Tobin Y.M. Elevated serum nitric oxide levels in patients with inflammatory arthritis associated with co-expression of inducible nitric oxide synthase andprotein kinase C-eta in peripheral blood monocyte-derived macrophages. J Rheumatol. 2003;30:2529–2534. [PubMed] [Google Scholar]
- 9.Kimura K. Mechanisms of active oxygen species reduction by non-steroidal anti-inflammatory drugs. Int J Biochem Cell Biol. 1997;29:437–446. doi: 10.1016/s1357-2725(96)00144-6. [DOI] [PubMed] [Google Scholar]
- 10.Altman R., Asch E., Bloch D., Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Arthritis Rheum. 1986;29:1039–1049. doi: 10.1002/art.1780290816. [DOI] [PubMed] [Google Scholar]
- 11.Bolognese J.A., Schnitzer T.J., Ehrich E.W. Response relationship of VAS and Likert scales in osteoarthritis efficacy measurement. Osteoarthritis Cartilage. 2003;11:499–507. doi: 10.1016/s1063-4584(03)00082-7. [DOI] [PubMed] [Google Scholar]
- 12.Angel M.F., Ramasastry S.S., Swartz W.M. The critical relationship between free radicals and degrees of ischemia: Evidence for tissue intolerance of marginal perfusion. Plast Reconstr Surg. 1988;81:233–239. doi: 10.1097/00006534-198802000-00017. [DOI] [PubMed] [Google Scholar]
- 13.Green L.C., Wagner D.A., Glogowski J. Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal Biochem. 1982;126:131–138. doi: 10.1016/0003-2697(82)90118-x. [DOI] [PubMed] [Google Scholar]
- 14.Sun Y., Oberley L.W., Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem. 1988;34:497–500. [PubMed] [Google Scholar]
- 15.Blanco F.J., Guitian R., Vazquez-Martul E. Osteoarthritis chondrocytes die by apoptosis. A possible pathway for osteoarthritis pathology. Arthritis Rheum. 1998;41:284–289. doi: 10.1002/1529-0131(199802)41:2<284::AID-ART12>3.0.CO;2-T. [DOI] [PubMed] [Google Scholar]
- 16.Chaturvedi V., Handa R., Rao D.N., Wali J.P. Estimation & significance of serum & synovial fluid malondialdehyde levels in rheumatoid arthritis. Indian J Med Res. 1999;109:170–174. [PubMed] [Google Scholar]
- 17.Bartosiewicz G., Mezes M., Nemet J. Changes in lipid, peroxide, and anti-oxidant blood levels during pi roxicam (Hotemin) treatment. Ther Hung. 1993;41:67–71. [PubMed] [Google Scholar]
- 18.Gonzalez E., de la Cruz C., de Nicolas R. Long-term effect of nonsteroidal anti-inflammatory drugs on the production of cytokines and other inflammatory mediators by blood cells of patientswith osteoarthritis. Agents Actions. 1994;41:171–178. doi: 10.1007/BF02001912. [DOI] [PubMed] [Google Scholar]
- 19.Hashimoto S., Ochs R.L., Komiya S., Lotz M. Linkage of chondrocyte apoptosis and cartilage degradation in human osteoarthritis. Arthritis Rheum. 1998;41:1632–1638. doi: 10.1002/1529-0131(199809)41:9<1632::AID-ART14>3.0.CO;2-A. [DOI] [PubMed] [Google Scholar]
- 20.Karan A., Karan M.A., Vural P. Synovial fluid nitric oxide levels in patients with knee osteoarthritis. Clin Rheumatol. 2003;22:397–399. doi: 10.1007/s10067-003-0761-y. [DOI] [PubMed] [Google Scholar]
- 21.Marklund S.L., Bjelle A., Elmqvist L.G. Superoxide dismutase isoenzymes of the synovial fluid in rheumatoid arthritis and in reactive arthritides. Ann Rheum Dis. 1986;45:847–851. doi: 10.1136/ard.45.10.847. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Uzun H., Tuzun S., Ozaras N. The effect of flurbiprofen and tiaprofenic acid on serum cytokine levels of patients with osteoarthrosis. Acta Orthop Scand. 2001;72:499–502. doi: 10.1080/000164701753532844. [DOI] [PubMed] [Google Scholar]
- 23.Pilbeam C.C., Fall P.M., Alander C.B., Raisz L.G. Differential effects of nonsteroidal anti-inflammatory drugs on constitutive and inducible prostaglandin G/H synthase in cultured bone cells. J Bone Miner Res. 1997;12:1198–1203. doi: 10.1359/jbmr.1997.12.8.1198. [DOI] [PubMed] [Google Scholar]
- 24.Orhan H., Sahin G. In vitro effects of NSAIDs and paracetamol on oxidative stress-related parameters of human erythrocytes. Exp Toxicol Pathol. 2001;53:133–140. doi: 10.1078/0940-2993-00179. [DOI] [PubMed] [Google Scholar]
- 25.Clancy R.M., Amin A.R., Abramson S.B. The role of nitric oxide in inflammation and immunity. Arthritis Rheum. 1998;41:1141–1151. doi: 10.1002/1529-0131(199807)41:7<1141::AID-ART2>3.0.CO;2-S. [DOI] [PubMed] [Google Scholar]
- 26.Amin A.R., Di Cesare P.E., Vyas P. The expression and regulation of nitric oxide synthase in human osteoarthritis-affected chondrocytes: Evidence for up-regulated neuronal nitricoxide synthase. J Exp Med. 1995;182:2097–2102. doi: 10.1084/jem.182.6.2097. [DOI] [PMC free article] [PubMed] [Google Scholar]